| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 1,766,813 | | Cost of Revenue | 1,463,169 | | | Gross Profit | 303,644 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 79,744 | | Non Recurring | 27,416 | | Others | 134,458 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 62,026 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 770 | | Earnings Before Interest And Taxes | 62,796 | | Interest Expense | 125,622 | | Income Before Tax | (62,826) | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | (62,826) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (62,826) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($62,826) |
|
1.48% Nasdaq 0.00%
Income Statement
